Friday 6 November 2026 Export AMGN’s income statement to Excel — free account

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024.

Revenue: +8.45%
EPS: +19.4%
Free cash flow: −0.16%
Total debt: −1.06%

Quarter to September 2026, against a year earlier

461.71 1.43 +0.31%

Follow AMGN

Alert me

Market cap: $248.8B
P/E: 26.6×
Fwd P/E: 29.6×
Dividend yield: 2.15%
F-score: 7/9
Altman Z: 1.69
Beneish M: −2.27
Dividend safety: 56/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	22.84	24.30	22.33	24.25
P/S ratio Full definition →		4.79	5.10	5.13	5.86
P/FCF ratio Full definition →		22.97	23.28	20.07	24.93
P/Operating CF Full definition →		109.85	86.80	48.86	53.77
P/B ratio Full definition →		20.34	20.67	16.73	19.51
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		6.03	6.32	6.27	6.91
EV/EBITDA Full definition →		14.34	14.83	14.48	16.30
EV/Operating CF Full definition →		22.25	21.87	19.14	22.34
EV/FCF Full definition →		28.90	28.82	24.52	29.39
Quick Ratio Full definition →		0.73	0.85	0.95	1.01
Current Ratio Full definition →		1.14	1.26	1.37	1.48
Net Debt/EBITDA Full definition →		11.81	11.97	9.36	0.00
Debt/Assets Full definition →		60.28%	61.97%	59.92%	56.23%
Debt/Equity Full definition →		6.31	6.24	4.90	3.76
Asset Turnover Full definition →		0.40	0.41	0.42	0.42
Operating CF/Net income Full definition →		1.20	1.20	1.69	1.10
Capex/Depreciation Full definition →		(0.57)	(0.64)	(0.46)	0.00
Interest Coverage Full definition →		4.17	4.06	5.22	5.68
Research and Development Expense of Revenue Full definition →		21.71%	19.95%	18.58%	20.37%
Selling, General and Administrative Expense of Revenue Full definition →		19.79%	18.59%	17.36%	16.21%
Intangible Assets out of Total Assets Full definition →		0.45	0.43	0.41	0.40
Share Based Compensation of Revenue Full definition →		1.27%	0.87%	1.64%	0.00%
Graham Net Nets Full definition →		(0.30)	(0.27)	(0.25)	(0.21)
Graham Number Full definition →		72.03	74.46	88.88	0.00
Earnings Yield Full definition →		4.38%	4.12%	4.48%	4.12%
Free Cash Flow Yield Full definition →		4.35%	4.30%	4.98%	4.01%
Revenue per Share Full definition →		18.34	15.96	18.62	19.16
Operating CF per Share Full definition →		2.98	4.05	7.41	7.84
Capex per Share Full definition →		(1.19)	(1.32)	(0.95)	0.00
Free Cash Flow per Share Full definition →		1.79	2.74	6.46	7.84
Cash per Share Full definition →		16.97	22.29	25.91	24.38
Shareholders Equity per Share Full definition →		16.09	17.02	21.64	26.53
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		16.09	17.02	21.64	26.53
Free Cash Flow Full definition →		961.00	1,477.00	3,489.00	4,241.00
Working Capital Full definition →		3,568.00	6,520.00	9,459.00	11,132.00
Capital Expenditures Full definition →		(642.00)	(712.00)	(513.00)	(587.00)
Net Current Asset Value Full definition →		(52,871.00)	(51,839.00)	(48,990.00)	(47,333.00)
EV/EBIT Full definition →		24.40	22.26	20.90	21.32
Capex to Sales Full definition →		0.07	0.08	0.05	0.00
Price to Operating Income Full definition →		19.39	17.98	17.11	18.08
Other line items
Average Receivables Full definition →		8,176.00	8,635.00	9,464.00	9,421.50
Average Payables Full definition →		2,137.50	2,670.50	2,937.50	11,835.50
Average Inventory Full definition →		6,611.50	6,457.50	6,401.50	6,367.50
Average Assets Full definition →		91,212.50	90,935.50	91,768.00	93,094.50
Average Common Equity Full definition →		7,267.50	7,698.50	9,558.00	11,985.50

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly